98%
921
2 minutes
20
Background: Dengue has an increased worldwide epidemic potential with the global rising temperature due to climate change. Heat and rainfall are known to influence seasonal patterns of dengue transmission over the course of weeks to months. However, there is a gap in knowledge about the short-term effect of heat on dengue severity. We aimed to quantify the effect of ambient temperature on dengue hospitalization risk in Brazil.
Methods: Daily dengue hospitalization counts and average daily ambient temperature from 2010 to 2019 were analyzed from Brazil. We applied the case time series design combined with a distributed lag nonlinear model framework to estimate relative risk (RR) estimates for dose-response and lag-response structures for the association of temperature and dengue hospitalization. We estimate the overall dengue hospitalization RR for the whole country as well as for each of the five macroregions.
Results: A total of 579,703 hospital admissions due to dengue occurred between 2010 and 2019. We observed a positive association between high temperatures and a high risk of hospitalization across the country. Under extreme heat (95th percentile of temperature), the RR was 3.47 (95% confidence interval: 2.88, 4.19) compared with minimum hospitalization risk. This association was mainly driven by an immediate effect of heat (lag 0) and was similar for the Northeast, Center-West, Southeast, and South regions, but unclear for the North. The risk was of greater magnitude among females and those aged ≥65 years.
Conclusion: Short-term high temperatures are associated with an increase in the risk of hospitalization by dengue.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688019 | PMC |
http://dx.doi.org/10.1097/EE9.0000000000000360 | DOI Listing |
Interact J Med Res
September 2025
Department of Medicine, MacKay Medical College, New Taipei, Taiwan.
Background: Dengue fever remains the most significant vector-borne disease in Southeast Asia, imposing a substantial burden on public health systems. Global warming and increased international mobility may exacerbate the disease's prevalence. Furthermore, the unprecedented COVID-19 pandemic may have influenced the epidemiological patterns of dengue.
View Article and Find Full Text PDFPLoS Negl Trop Dis
September 2025
División de Inmunología, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva, Huila, Colombia.
Background: Dengue and chikungunya are arboviral diseases with overlapping clinical characteristics. Dengue virus (DENV) is endemic in Colombia, and in 2014/2015, the chikungunya virus (CHIKV) caused an epidemic that resulted in over 350,000 cases. Since then, both viruses have been actively co-circulating.
View Article and Find Full Text PDFNew Microbes New Infect
October 2025
Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Introduction: Dengue fever, the most prevalent arthropod-borne viral disease, causes ∼400 million infections annually. Although thrombocytopenia is commonly associated with dengue, how it evolves in relation to viral load and immune responses remains poorly understood. This study aimed to elucidate platelet-virus-immune interactions in acute dengue by systematically tracking of viral load, platelet parameters, and leukocyte dynamics.
View Article and Find Full Text PDFVirology
September 2025
Department of Medicine, Democritus University of Thrace, Alexandroupolis, Evros, Greece.
Background: Dengue virus (DENV) is a major global health challenge, causing over 7.6 million reported cases in 2024. Neutralizing monoclonal antibodies (NmAbs) have emerged as promising therapeutics to address the limitations of vaccines and lack of antivirals, but their development is complicated by viral diversity, "breathing" dynamics, and antibody-dependent enhancement (ADE).
View Article and Find Full Text PDFJ Travel Med
September 2025
Public Health Agency of Sweden, Solna, Sweden.
We describe a Qdenga-induced DENV-2-infection in a Swedish traveler. Comparative sequencing suggests that the vaccine contained a small fraction of identical virus as detected in the patient, suggesting a selection of a DENV-2-substrain with unusual amino acid substitutions. Further research on selection of, and possible effects of, Qdenga-substrain-infections is warranted.
View Article and Find Full Text PDF